Ehsan Abolhasani

Ehsan Abolhasani

Auto-generated profile, based on publicly available information

Ehsan Abolhasani

Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2012 in Integrative Cancer Therapies
Verified
Journal Article
Open access
PDF file
YPYunes Panahi
Yunes Panahi
ASAlireza Saadat
Alireza Saadat
ASAmirhossein Sahebkar
Amirhossein Sahebkar
FHFarshad Hashemian
Farshad Hashemian
MTMojgan Taghikhani
Mojgan Taghikhani
EAEhsan Abolhasani
Ehsan Abolhasani
Background. Nausea and vomiting are among the most prevalent and disturbing side effects of chemotherapy. Therefore, there is a need for additional antiemetic agents that could effectively reduce chemotherapy-induced nausea and vomiting (CINV), whether alone or in combination with current standard therapies. Since clinical data on the effectiveness of ginger in patients with advanced breast cancer is lacking, the present study aimed to evaluate the effects of ginger against both acute and delayed forms of CINV in a population with advanced breast cancer as the main malignancy. Methods. In this pilot, randomized, open-label clinical trial, 100 women (mean age = 51.83 ± 9.18 years) with advanced breast cancer who were initially assigned to standard chemotherapy protocol with docetaxel, epirubicin, and cyclophosphamide (the TEC regimen) were randomized to receive ginger (1.5 g/d in 3 divided doses every 8 hours) plus standard antiemetic regimen (granisetron plus dexamethasone; the ginger group) or standard antiemetic regimen alone (control group). The duration of treatment with ginger was specified to 4 days from the initiation of chemotherapy. Prevalence, score, and severity of nausea, vomiting, and retching were assessed using a simplified form of Rhodes index in the first 6 hours, between 6 to 24 hours, and days 2, 3, and 4 postchemotherapy. Results. A significantly lower prevalence of nausea was observed in the ginger group during 6 to 24 hours postchemotherapy. Despite this effect, no other significant additional benefit from ginger (1.5 g/d) was observed against prevalence or severity of nausea, vomiting, and retching in any of the assessed periods. Conclusion. Addition of ginger (1.5 g/d) to standard antiemetic therapy (granisetron plus dexamethasone) in patients with advanced breast cancer effectively reduces the prevalence of nausea 6 to 24 hours postchemotherapy. However, there is no other additional advantage for ginger in reducing prevalence or severity of acute or delayed CINV.

10 January 2023 in Neurology
Verified
Journal Article
Closed access
PDF file
EAEhsan Abolhasani
Ehsan Abolhasani
VHVladimir Hachinski
Vladimir Hachinski
NGNargess Ghazaleh
Nargess Ghazaleh
MAMahmoud Reza Azarpazhooh
Mahmoud Reza Azarpazhooh
NMNaghmeh Mokhber
Naghmeh Mokhber
JMJanet Martin
Janet Martin
BACKGROUND AND OBJECTIVE. Studies of association between air pollution and incidence of dementia have shown discrepant results. The aim of this study was to evaluate the association between air pollution and dementia. METHODS. In this systematic review and meta-analysis, PubMed, MEDLINE, EMBASE, PsycINFO, Scopus, Web of Science were searched and updated in August 2021. Population-based cohort studies that reported on hazard ratio (HR) of dementia in association to exposure to fine particulate matter (PM2·5), nitrogen oxides (NOX), nitrogen dioxide (NO2), or ozone (O3) in those > 40 years old were included. Data were extracted by two independent investigators. The main outcome was the pooled HR for dementia per increment of pollutant, calculated using a random-effects model. Results were reported in accordance with PRISMA guidelines. The protocol was registered in PROSPERO (registration number: CRD42020219036). RESULTS. A total of 20 studies were included in the systematic review, and 17 provided data for the meta-analysis. The total included population was 91,391,296, with 5,521,111 (6%) being diagnosed with dementia. A total of twelve, five, six, and four studies were included in the meta-analyses of PM2·5, NOX, NO2, and O3, respectively. The risk of dementia increased by 3% per 1μg/m3 increment in PM2·5 (HR, 1.03; 95%CI, [1.02–1.05]; I2 = 100%). The association between dementia per 10μg/m3 increment in NOX (HR, 1.05; 95%CI, [0.99–1.13]; I2 = 61%), NO2 (HR, 1.03; 95%CI, [1.00–1.07]; I2 = 94%), and O3 level (HR, 1.01; 95%CI, [0.91–1.11]; I2 = 82%) was less clear, though a significant association could not be ruled out, and there was high heterogeneity across studies. DISCUSSION. Existing evidence suggests a significant association between exposure to PM2·5 and incidence of dementia, and non-significant association between dementia and NOX, NO2, and O3 exposure. However, results should be interpreted in light of the small number of studies and high heterogeneity of effects across studies.

1 December 2012 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
MYM. Yousefi
M. Yousefi
BBB. Barikbin
B. Barikbin
MKM. Kamalinejad
M. Kamalinejad
EAE. Abolhasani
E. Abolhasani
AEA. Ebadi
A. Ebadi
SHS. Hejazi
S. Hejazi

28 February 2012 in Nutrition & Dietetics
Verified
Journal Article
Closed access
PDF file
YPYunes Panahi
Yunes Panahi
BPBahram Pishgoo
Bahram Pishgoo
HJHamid R. Jalalian
Hamid R. Jalalian
EMElaheh Mohammadi
Elaheh Mohammadi
HTHamid R. Taghipour
Hamid R. Taghipour
EAEhsan Abolhasani
Ehsan Abolhasani

10 July 2013 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
MMM. Mahmoudi-Rad
M. Mahmoudi-Rad
EAE. Abolhasani
E. Abolhasani
HMH. Moravvej
H. Moravvej
NMN. Mahmoudi-Rad
N. Mahmoudi-Rad
YMY. Mirdamadi
Y. Mirdamadi

10 May 2018 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
HMH. Moravvej
H. Moravvej
FAF. Abdollahimajd
F. Abdollahimajd
MNM.‐H. Naseh
M.‐H. Naseh
ZPZ. Piravar
Z. Piravar
EAE. Abolhasani
E. Abolhasani
HNH. Niknejad
H. Niknejad